- Research
- 2022-2026 Research Strategy
- Open Clinical Trials
- Closed Clinical Trials
- What is a Clinical Trial?
- Why Participate in a Clinical Trial
- Remote Telehealth Pre-Screening Process
- Research Achievements
- Publications
- Research Development and Funding
- Participating Institutions
- International Collaboration
- BCT Trials & Projects Summary
- Translational Research
- Clinical Fellowship Program
- International Fellowship Support
- Annual Scientific Meeting
- Travel Grants and Awards
- About
- Our Impact
- Fundraise
- Donate
- Researcher Login
- Cart
WHO CAN TAKE PART IN ROSALIE?
ROSALIE may be right for you if:
- You are female and 18 years of age or older
- You have breast cancer that is only in the breast (that is, has not spread to lymph nodes in the chest or the chest wall)
- You have had at least 8 weeks of chemotherapy and then surgery on your breast after chemotherapy
- Surgery found that there is no invasive cancer left in the breast
- Some people may have a small amount (no more than 1cm) of ductal carcinoma in situ (DCIS) remaining after treatment. DCIS is an early non-invasive form of breast cancer. DCIS remaining after treatment is called residual DCIS. You can also take part in ROSALIE if you have residual DCIS.

Please click here for more information on Questionnaires in clinical trials.
IF YOU THINK THE ROSALIE TRIAL MIGHT BE RIGHT FOR YOU …
Please speak to your regular doctor or oncologist about a referral to a participating site.
You can give your doctor/oncologist the link to the trial page or the public registry for further information.
